Skip to main content

Want a detailed portfolio tracker?

MindWalk (HYFT) P/E (2017 - 2026)

MindWalk (HYFT) P/E from Jan 3, 2017 to Jul 21, 2026. The TTM MindWalk (HYFT) P/E is -6.91. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MindWalk (HYFT)

YearP/EChange
2026-6.91+128.33%
2025-3.03+440.60%
2024-0.56-82.24%
2023-3.15-49.05%
2022-6.19-25.44%
2021-8.30-92.48%
2020-110.37+2251.17%
2019-4.69-16.45%
2018-5.62+205.10%
2017-1.84N/A

Comparison MindWalk (HYFT) P/E with competitors

MindWalk (HYFT) P/E is -6.91.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.08%
FGENFibroGen Inc0.24-103.47%
CHRSCoherus Biosciences Inc0.85-112.28%
FBIOFortress Biotech Inc0.95-113.74%
ORMPOramed Pharmaceuticals Inc1.50-121.76%
AGENAgenus Inc3.01-143.57%
INVAInnoviva Inc3.15-145.66%
VXRTVaxart Inc3.55-151.38%
CRMDCorMedix Inc3.63-152.52%
CVACCureVac N.V.4.45-164.35%
GLPGGalapagos NV4.86-170.33%
SRPTSarepta Therapeutics Inc4.88-170.67%
ABEOAbeona Therapeutics Inc5.39-177.99%
ABUSArbutus Biopharma Corp5.60-181.00%
ZVRAZevra Therapeutics Inc5.89-185.22%
SPROSpero Therapeutics Inc6.23-190.16%
CGENCompugen Ltd6.31-191.40%
RIGLRigel Pharmaceuticals6.87-199.48%
SLXNSilexion Therapeutics Corp7.30-205.61%
OMEROmeros Corporation9.26-234.02%
AUPHAurinia Pharmaceuticals Inc9.58-238.75%
PLXProtalix BioTherapeutics Inc10.89-257.65%
ACADAcadia Pharmaceuticals Inc11.73-269.77%
TBPHTheravance Biopharma Inc12.26-277.50%
ADMAAdma Biologics Inc12.42-279.76%
HRMYHarmony Biosciences Holdings Inc13.82-300.05%
SABSSAB Biotherapeutics Inc14.14-304.63%
NAGENiagen Bioscience Inc14.82-314.50%
INCYIncyte Corp15.82-329.04%
REGNRegeneron Pharmaceuticals Inc15.86-329.53%
PBYIPuma Biotechnology Inc17.32-350.65%
CPRXCatalyst Pharmaceuticals Inc17.44-352.44%
EXELExelixis Inc17.54-353.87%
TGTXTG Therapeutics Inc18.97-374.54%
MDXGMimedx Group Inc20.55-397.51%
XOMAXOMA Royalty Corp22.87-431.13%
ARGXArgen X SE24.30-451.73%
CTMXCytomX Therapeutics Inc24.82-459.30%
XOMAOXOMA Royalty Corp25.34-466.89%
HALOHalozyme Therapeutics Inc25.62-470.92%
XOMAPXOMA Royalty Corp25.67-471.59%
VRTXVertex Pharmaceuticals Inc27.99-505.24%
RPRXRoyalty Pharma plc - Class A28.69-515.27%
SLNOSoleno Therapeutics Inc29.02-520.02%
ASNDAscendis Pharma A/S30.09-535.51%
LGNDLigand Pharmaceuticals Inc - Class B37.91-648.81%
APLSApellis Pharmaceuticals Inc39.02-664.86%
BMRNBiomarin Pharmaceutical Inc42.21-711.05%
KRYSKrystal Biotech Inc45.34-756.38%
ONCBeiGene Ltd69.54-1106.65%
PHARPharming Group N.V.75.03-1186.05%
TECHBio-Techne Corp101.96-1575.93%
VCELVericel Corp109.92-1691.20%
ALNYAlnylam Pharmaceuticals Inc117.96-1807.64%
GMABGenmab140.29-2130.82%
TLXTelix Pharmaceuticals Ltd162.15-2447.29%
CORTCorcept Therapeutics Inc212.86-3181.28%